Clinical Trials Browser

Phase NA × Autoimmune Diseases × Population Groups × Clear all

NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Phase NA Not yet recruiting

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases